PerkinElmer Inc (NYSE:PKI)
| 176.44 Delayed Data As of Oct 22 |  -0.06 / -0.03%Today’s Change | 119.95 Today|||52-Week Range 192.00 | +22.95% Year-to-Date |
PKI Regular Dividend: PKI began trading ex-dividend on 10/21/21. A $0.07 dividend will be paid to shareholders of record as of 10/22/21.
Latest PKI News | Press Releases
Today’s Trading
| Previous close | 176.50 |
| Today’s open | 176.75 |
| Day’s range | 175.17 - 178.08 |
| Volume | 300,405 |
| Average volume (3 months) | 705,554 |
| Market cap | $19.8B |
Data as of 4:00pm ET, 10/22/2021
Growth & Valuation
| Earnings growth (last year) | +217.93% |
| Earnings growth (this year) | +21.36% |
| Earnings growth (next 5 years) | +16.83% |
| Revenue growth (last year) | +31.18% |
| P/E ratio | 16.8 |
| Price/Sales | 4.25 |
| Price/Book | 5.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BIOBio Rad Laboratories... | -6.68 | -0.88% |
| WATWaters Corp | +3.50 | +0.97% |
| QGENQiagen NV | +0.50 | +0.93% |
| BRKRBruker Corp | +0.10 | +0.13% |
Data as of 4:00pm ET, 10/22/2021
Financials
| Next reporting date | November 3, 2021 |
| EPS forecast (this quarter) | $1.74 |
| Annual revenue (last year) | $3.8B |
| Annual profit (last year) | $728.1M |
| Net profit margin | 19.25% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
